Fundai

Darou Pakhsh Raw Materials Production Company (DTAMAD) income statement

Operating revenue through to net profit and earnings per share

Ticker
DTAMAD
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue41,090,46615,019,79912,259,4708,229,7475,947,3545,220,170
Cost of operating revenue-15,825,017-7,982,091-7,122,940-4,346,559-2,985,970-2,112,713
Gross profit (loss)25,265,4497,037,7085,136,5303,883,1882,961,3843,107,457
Selling, general and administrative expenses-1,412,726-646,144-535,899-433,797-222,160-217,800
Other income38,862408,179823,98575,03840,08797,315
Other expenses-46,125-29,924-68,948000
Operating profit (loss)23,845,4606,769,8195,355,6683,524,4292,779,3112,986,972
Finance costs-845,625-411,695-408,497-315,833-198,406-40,382
Other non-operating income and expenses1235,30625,61722,10412,091-7,084
Profit (loss) from continuing operations before tax22,999,9586,363,4304,972,7883,230,7002,592,9962,939,506
Current year tax-4,917,232-1,069,047-833,681-606,335-388,061-488,791
Net profit (loss) from continuing operations18,082,7265,294,3834,127,4662,624,3652,204,9352,450,715
Net profit (loss)18,082,7265,294,3834,127,4662,624,3652,204,9352,450,715
Basic earnings (loss) per share6,464 rials7,433 rials5,784 rials3,676 rials3,089 rials3,438 rials
Net earnings (loss) per share, rials6,459 rials7,405 rials5,773 rials3,671 rials3,084 rials3,428 rials
Capital2,800,000715,000715,000715,000715,000715,000

Reporting periods

87 periods are on file for this report, from the period ending 1381/12/29 to the period ending 1405/06/31.